Texas A&M-UTMB team identifies potential drug to treat SARS-CoV-2
A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by a research team from Texas A&M University and The University of Texas Medical Branch (UTMB). The medication bepridil, which goes by the trade name Vascor, is currently approved by the U.S.…
Details